Mechanisms of oral carcinogenesis induced by dibenzo[a,l]pyrene: An environmental pollutant and a tobacco smoke constituent
暂无分享,去创建一个
K. Ahn | S. Amin | T. Cooper | K. El-Bayoumy | C. Aliaga | Kun-Ming Chen | Shang-Min Zhang | Yuan-Wan Sun | J. Guttenplan | Arun K. Sharma | Wieslawa Kosinska | Joseph Deltondo | Richard D. Bruggeman | Joseph B. Guttenplan | Kun Jiang
[1] K. Rudolph,et al. DNA damage checkpoints in stem cells, ageing and cancer , 2012, Nature Reviews Molecular Cell Biology.
[2] K. Ahn,et al. Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: a potential new model for oral cancer , 2012, International journal of cancer.
[3] S. Amin,et al. Induction of ovarian cancer and DNA adducts by Dibenzo[a,l]pyrene in the mouse. , 2012, Chemical research in toxicology.
[4] S. Amin,et al. Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a,l]pyrene by HPLC-MS/MS. , 2011, Chemical research in toxicology.
[5] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[6] R. Mendes,et al. An overview on the expression of cyclooxygenase-2 in tumors of the head and neck. , 2009, Oral oncology.
[7] A. Molinolo,et al. Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model. , 2009, Cancer research.
[8] V. Patel,et al. Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer , 2009, Cancer Prevention Research.
[9] Ru-Fang Yeh,et al. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. , 2009, Carcinogenesis.
[10] K. Wong. Oral-Specific Chemical Carcinogenesis in Mice: An Exciting Model for Cancer Prevention and Therapy , 2009, Cancer Prevention Research.
[11] M. George,et al. Mutations induced by benzo[a]pyrene and dibenzo[a,l]pyrene in lacI transgenic B6C3F1 mouse lung result from stable DNA adducts. , 2008, Mutagenesis.
[12] S. Shetty,et al. Regulation of Plasminogen Activator Inhibitor-1 Expression by Tumor Suppressor Protein p53* , 2008, Journal of Biological Chemistry.
[13] P. Laurent-Puig,et al. Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma , 2008, BMC Medical Genomics.
[14] J. Eyfjörd,et al. MYC amplification and TERT expression in breast tumor progression. , 2007, Cancer genetics and cytogenetics.
[15] Clifton D Fuller,et al. Conditional survival in head and neck squamous cell carcinoma , 2007, Cancer.
[16] K. Pavelka,et al. Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[17] C. Leonetti,et al. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. , 2006, Cancer cell.
[18] C. Haglund,et al. Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. , 2006, Oncology reports.
[19] John T. Powers,et al. Oncogenes and the DNA Damage Response: Myc and E2F1 Engage the ATM Signaling Pathway to Activate p53 and Induce Apoptosis , 2006, Cell cycle.
[20] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[21] Xiaolong Wei,et al. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. , 2005, Cancer cell.
[22] D. Desai,et al. Effects of 3H-1,2-dithiole-3-thione, 1,4-phenylenebis(methylene)selenocyanate, and selenium-enriched yeast individually and in combination on benzo[a]pyrene-induced mutagenesis in oral tissue and esophagus in lacZ mice. , 2004, Mutation research.
[23] Martin Schuler,et al. Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis , 2004, Science.
[24] S. Amin,et al. Mammary carcinogenesis and molecular analysis of in vivo cII gene mutations in the mammary tissue of female transgenic rats treated with the environmental pollutant 6-nitrochrysene. , 2003, Carcinogenesis.
[25] L. Magnelli,et al. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma. , 2003, The American journal of pathology.
[26] W. El-Deiry,et al. The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis , 2002, Cancer biology & therapy.
[27] D Hoffmann,et al. The Less Harmful Cigarette: a Controversial Issue. a Tribute to Ernst L. Wynder , 2000 .
[28] K. Mancer,et al. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma , 2001, Oncogene.
[29] Delin Chen,et al. Deacetylation of p53 modulates its effect on cell growth and apoptosis , 2000, Nature.
[30] R. Maronpot,et al. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. , 1999, Cancer research.
[31] Kevin Ryan,et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 , 1998, The EMBO journal.
[32] T. Devereux,et al. Predominant p53 G→A Transition Mutation and Enhanced Cell Proliferation in Uterine Sarcomas of CBA Mice Treated with 1,2-Dimethylhydrazine , 1998, Toxicologic pathology.
[33] A. Olshan,et al. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[34] M. Tang,et al. Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.
[35] A. Sarasin,et al. Mutagenicity of a unique 8-oxoguanine in a human Ha-ras sequence in mammalian cells. , 1995, Carcinogenesis.
[36] S. Amin,et al. Synthesis of Fjord region diol epoxides as potential ultimate carcinogens of dibenzo[a,l]pyrene. , 1994, Chemical research in toxicology.
[37] G. Snow,et al. Risk of multiple primary tumors following oral squamous‐cell carcinoma , 1994, International journal of cancer.
[38] T. Goodrow,et al. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[39] W. Blot,et al. Second primary tumors in patients with oral cancer , 1992, Cancer.
[40] D. Lane,et al. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa , 1992, The Journal of pathology.
[41] A. Malliri,et al. Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. , 1991, British Journal of Cancer.
[42] S. Lippman,et al. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. , 1989, International journal of radiation oncology, biology, physics.
[43] M. Spitz,et al. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. , 1989, International journal of radiation oncology, biology, physics.
[44] Kramer Ir,et al. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. , 1978 .
[45] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[46] A. Jemal,et al. Global Cancer Statistics , 2011 .
[47] Andreas Luch,et al. On the impact of the molecule structure in chemical carcinogenesis. , 2009, EXS.
[48] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[49] L. Kowalski,et al. Presentation Risk factors for second cancers of the upper respiratory and digestive systems: A case-control study , 1991 .
[50] L. Kowalski,et al. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. , 1991, Journal of clinical epidemiology.
[51] S. Taylor. Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.
[52] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[53] L. Sobin,et al. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. , 1978, Oral surgery, oral medicine, and oral pathology.